Tonix Pharmaceuticals Holding (TNXP) Non-Current Deffered Revenue (2010 - 2018)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Non-Current Deffered Revenue came in at $12000.0 in Q4 2018, little changed year-on-year from $12000.0 in Q4 2017, and up 1100.0% quarter-over-quarter from $1000.0 in Q2 2018.
Tonix Pharmaceuticals Holding (TNXP) Non-Current Deffered Revenue (2010 - 2018) Analysis & Trends
Tonix Pharmaceuticals Holding's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $12000.0 for Q4 2018.
- On a quarterly basis, Non-Current Deffered Revenue changed 0.0% year-over-year to $12000.0 in Q4 2018; TTM through Dec 2018 was $12000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $12000.0, changed 0.0% from the prior year.
- Non-Current Deffered Revenue advanced to $12000.0 in Q4 2018 per TNXP's latest filing, from $1000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $112000.0 in Q4 2015 and bottomed at $1000.0 in Q2 2018.
- The 5-year median for Non-Current Deffered Revenue is $48000.0 (2014), against an average of $46214.3.
- Across the five-year window, Non-Current Deffered Revenue soared 1016.67% in 2015 and sank 72.73% in 2017, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $52000.0 in 2014, then jumped by 115.38% to $112000.0 in 2015, then tumbled by 60.71% to $44000.0 in 2016, then sank by 72.73% to $12000.0 in 2017, then changed by 0.0% to $12000.0 in 2018.
- Per Business Quant, the three latest TNXP Non-Current Deffered Revenue figures stand at $12000.0 (Q4 2018), $1000.0 (Q2 2018), and $12000.0 (Q4 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 12,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Sep 30, 2017 | 18,000.00 |
| Dec 31, 2016 | 44,000.00 |
| Mar 31, 2016 | 97,000.00 |
| Dec 31, 2015 | 112,000.00 |
| Sep 30, 2015 | 77,000.00 |
| Jun 30, 2015 | 65,000.00 |
| Mar 31, 2015 | 67,000.00 |
| Dec 31, 2014 | 52,000.00 |
| Sep 30, 2014 | 54,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Dec 31, 2013 | 19,710.00 |
| Sep 30, 2013 | 13,750.00 |
| Jun 30, 2013 | 15,137.00 |
| Mar 31, 2013 | 17,424.00 |
| Dec 31, 2012 | 20,000.00 |
| Sep 30, 2012 | 27,543.00 |